Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-01-18 @ 9:34 AM
Study NCT ID:
NCT03656718
Status:
COMPLETED
Last Update Posted:
2025-11-12
First Post:
2018-08-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-28
First Submit QC Date:
None
Study First Post Date:
2018-09-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-06
Results First Submit QC Date:
None
Results First Post Date:
2025-02-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-02-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-28
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED